- Home
- NTLA vs MLR Comparison
NTLA vs MLR Comparison
Compare NTLA & MLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTLA
- MLR
- Stock Information
- Founded
- NTLA 2014
- MLR 1990
- Country
- NTLA United States
- MLR United States
- Employees
- NTLA N/A
- MLR N/A
- Industry
- NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MLR Construction/Ag Equipment/Trucks
- Sector
- NTLA Health Care
- MLR Consumer Discretionary
- Exchange
- NTLA Nasdaq
- MLR Nasdaq
- Market Cap
- NTLA 686.3M
- MLR 776.7M
- IPO Year
- NTLA 2016
- MLR 1994
- Fundamental
- Price
- NTLA $7.23
- MLR $40.19
- Analyst Decision
- NTLA Buy
- MLR Strong Buy
- Analyst Count
- NTLA 18
- MLR 1
- Target Price
- NTLA $39.44
- MLR $82.00
- AVG Volume (30 Days)
- NTLA 3.8M
- MLR 137.4K
- Earning Date
- NTLA 05-08-2025
- MLR 05-07-2025
- Dividend Yield
- NTLA N/A
- MLR 1.99%
- EPS Growth
- NTLA N/A
- MLR 7.89
- EPS
- NTLA N/A
- MLR 5.47
- Revenue
- NTLA $57,877,000.00
- MLR $1,257,500,000.00
- Revenue This Year
- NTLA N/A
- MLR N/A
- Revenue Next Year
- NTLA N/A
- MLR $18.55
- P/E Ratio
- NTLA N/A
- MLR $7.35
- Revenue Growth
- NTLA 59.55
- MLR 9.03
- 52 Week Low
- NTLA $5.90
- MLR $37.40
- 52 Week High
- NTLA $28.18
- MLR $78.25
- Technical
- Relative Strength Index (RSI)
- NTLA 43.76
- MLR 35.23
- Support Level
- NTLA $6.73
- MLR $39.17
- Resistance Level
- NTLA $7.76
- MLR $41.99
- Average True Range (ATR)
- NTLA 0.71
- MLR 1.95
- MACD
- NTLA 0.11
- MLR 0.48
- Stochastic Oscillator
- NTLA 68.91
- MLR 43.26
About NTLA Intellia Therapeutics Inc.
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.
About MLR Miller Industries Inc.
Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.